Ziyi Zhou

Ziyi Zhou

Auto-generated profile, based on publicly available information

Ziyi Zhou

School of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2025 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
Yanqiu HuangYanqiu Huang
Yanqiu Huang
YZYi Zhou
Yi Zhou
YXYadan Xu
Yadan Xu
XWXiaoyu Wang
Xiaoyu Wang
ZZZiyi Zhou
Ziyi Zhou
HWHui Wang
Hui Wang
Among hypertensive cohorts across different nations, the relationship between the triglyceride-glucose index (TyG) and its conjunction with obesity metrics in relation to cardiovascular disease (CVD) incidence and mortality remains to be elucidated. This study enrolled 9,283, 164,357, and 5,334 hypertensives from the National Health and Nutrition Examination Survey (NHANES), UK Biobank (UKBB), and Shanghai Pudong cohort. The related outcomes for CVD were defined by multivariate Cox proportional hazards models, Generalized Additive Models and Mendelian randomization analysis. Mediation analysis explored the mediating role of inflammatory markers in the above relationships. Five measures of insulin resistance were linked to CVD and related death in a U-shaped pattern, with the highest group having different risk increases. Higher glucose triglyceride-waist height ratio (TyG-WHTR) was linked to higher all-cause mortality (UKBB: HR 1.21, 95%CI 1.16–1.26, NHANES: HR 1.17, 95%CI 1.00–1.36), CVD mortality (UKBB: HR 1.36, 95%CI 1.23–1.49, NHANES: HR 1.32, 95%CI 1.00–1.72) risks. In the China Pudong cohort, higher triglyceride/high-density lipoprotein-cholesterol (TG/HDL_C) ratio was associated with higher risks of CVD and stroke (HR 1.31, 95%CI 1.00–1.73 and 1.67, 1.06–2.63). Inflammation markers like systemic inflammatory response index (SIRI) and C-reactive protein (CRP) partially explained these links, with CRP having a stronger effect. Genetically predicted TyG was also linked to stroke (OR 1.26, 95%CI 1.10–1.45) risk. An elevated TyG index and its related indices are significantly correlated with an increased risk of CVD and related mortality across three national cohorts. These indices are anticipated to serve as valid predictors of incident CVD and mortality in individuals with hypertension.

20 September 2022 in Circulation
Verified
Journal Article
Closed access
PDF file
FHFrederick Ho
Frederick Ho
ZZZiyi Zhou
Ziyi Zhou
FPFanny Petermann-Rocha
Fanny Petermann-Rocha
SPSolange Parra-Soto
Solange Parra-Soto
JBJirapitcha Boonpor
Jirapitcha Boonpor
Carlos Celis-MoralesCarlos Celis-Morales
Carlos Celis-Morales
Background: Studies of objectively measured physical activity (PA) have investigated acute cardiovascular outcomes but not heart failure (HF), an emerging chronic condition. This study aimed to investigate the dose-response relationship between device-measured PA and HF by intensity of PA. Methods: This was a prospective cohort study of 94 739 UK Biobank participants who had device-measured PA in 2013 to 2015 and were free from myocardial infarction and HF. PA was measured with a wrist-worn accelerometer, and time spent on light-, moderate-, and vigorous-intensity PA was extracted. Incident HF was ascertained from linked hospital and death records. Cox proportional hazard models with cubic penalized splines were used to study the associations, which were adjusted for sociodemographic and lifestyle factors. Competing risk was handled with cause-specific hazard ratios. Results: The overall incidence of HF was 98.5 per 10 000 person-years over a median 6.1 years of follow-up. Compared with participants who undertook no moderate- to vigorous-intensity PA, those who performed 150 to 300 min/wk of moderate-intensity PA (hazard ratio, 0.37 [95% CI, 0.34–0.41]) and 75 to 150 min/wk of vigorous-intensity PA (hazard ratio, 0.34 [95% CI, 0.25–0.46]) were at lower HF risk. The association between vigorous-intensity PA and HF was reverse-J shaped with a potentially lower risk reduction above 150 min/wk. Conclusions: Device-measured PA, especially moderate-intensity PA, was associated with a lower risk of HF. Current vigorous-intensity PA recommendations should be encouraged but not increased. In contrast, increasing moderate-intensity PA may be beneficial even among those meeting current recommendations.

16 August 2024 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Closed access
PDF file
YLYujia Lu
Yujia Lu
YZYu Chen Zhao
Yu Chen Zhao
KLKuangyu Liu
Kuangyu Liu
ABAlaina Bever
Alaina Bever
ZZZiyi Zhou
Ziyi Zhou
MSMingyang Song
Mingyang Song
Despite the recognized role of visceral adipose tissue (VAT) in carcinogenesis, its independent association with cancer risk beyond traditional obesity measures remains unknown due to limited availability of imaging data. We developed an estimation equation for VAT volume (L) using Elastic Net Regression based on demographic and anthropometric data in a subcohort of participants in the UK Biobank (UKB; N = 23,148) with abdominal MRI scans. This equation was externally validated in 2,713 participants from the 2017-2018 National Health and Nutrition Examination Survey (NHANES) according to sex, age, and race groups. We then applied the equation to the overall UKB cohort of 461,665 participants to evaluate the prospective association between estimated VAT (eVAT) and cancer risk using Cox proportional hazards models. We also calculated the population attributable risk (PAR) of cancer associated with eVAT and BMI. eVAT showed a high correlation with measured VAT in internal and external validations (r = 0.81-0.86). During a median 12-year follow-up in the UKB, we documented 37,397 incident cancer cases; eVAT was significantly associated with elevated risk of obesity-related and individual cancers, independent of BMI and waist circumference. PAR for total cancer associated with high (quartiles 2-4 vs 1) eVAT (9.0-11.6%) was higher than high BMI (Q2-4 vs 1; 5.0-8.2%). eVAT showed robust performance in both UKB and NHANES and was associated with cancer risk independent of BMI and waist circumference. This study provides a potential clinical tool for VAT estimation and underscores that VAT can be an important target for cancer prevention.

15 October 2024 in International Journal of Obesity
Verified
Journal Article
Open access
PDF file
TNTamta Nadaraia
Tamta Nadaraia
EWEd Whittaker
Ed Whittaker
IKIndira Kenyon
Indira Kenyon
JBJirapitcha Boonpor
Jirapitcha Boonpor
ZZZiyi Zhou
Ziyi Zhou
DMDaniel Mackay
Daniel Mackay
Background: This study aims to explore the association of childhood maltreatment with obesity and type 2 diabetes (T2D) in adulthood, and whether obesity is a mediator of the latter. Methods: In a retrospective cohort study using UK Biobank data, participants recalled childhood maltreatment. Linear regression, logistic regression, and Cox proportional hazard models were used to investigate the associations with body mass index (BMI), obesity, and T2D, adjusted for sociodemographic factors. Decomposition analysis was used to examine the extent to which T2D excess risk was attributed to BMI. Results: Of the 153,601 participants who completed the childhood maltreatment questions, one-third reported some form of maltreatment. Prevalence of adult obesity and incidence of T2D were higher with the number of reported childhood maltreatment types. People who reported ≥3 types of childhood maltreatment were at higher risk of obesity (OR 1.55, 95% CI 1.47–1.63) and incident T2D (HR 1.65, 95% CI 1.52–1.80). Excess T2D risk among those reporting maltreatment could be reduced by 39% if their BMI was comparable to participants who had not been maltreated, assuming causality. Conclusions: People who recalled maltreatment in childhood are at higher risk of T2D in adulthood, partly due to obesity.

23 May 2025 in medRxiv
Verified
Preprint
Open access
PDF file
MAMohammed Sherif Amin
Mohammed Sherif Amin
FHFrederick Ho
Frederick Ho
SPSolange Parra-Soto
Solange Parra-Soto
ZZZiyi Zhou
Ziyi Zhou
SNShinya Nakada
Shinya Nakada
JPJill P Pell
Jill P Pell
Background Mental health conditions (MHCs) affect both psychological health and biological systems and have been linked to cancer risk. However, evidence from epidemiological studies remains inconsistent. Aim The study aims to investigate the associations of five MHCs (depressive disorders (DD), anxiety disorders (AD), bipolar disorder (BD), schizophrenia (SZ), and post-traumatic stress disorder (PTSD)) with overall and site-specific cancer risk. Dose-response relationship by depressive symptom severity and effect modifications by sex were also explored. Methods A population-based prospective cohort study was conducted on 402,255 UK Biobank participants, who were free from cancer, with a median follow-up of 13.4 years. Cox proportional hazard models were used to examine the associations of the five MHCs, and self-reported depressive symptom severity with overall and site-specific incident cancers, adjusting for sociodemographic, lifestyle and health-related confounders. Results Over a median follow-up of 13.4 years, 68,065 (17%) incident cancer cases were recorded. DD (HR 1.18; 95% CI 1.13-1.23), AD (HR: 1.17, 95%CI: 1.11-1.24), and BD (HR: 1.29, 95%CI: 1.11-1.51) were associated with increased overall cancer risk. No significant association was found for SZ and PTSD. The associations of DD (HR: 1.27, 95%CI: 1.18-1.35) and BD (HR: 1.54, 95%CI: 1.26-1.88) were only significant in men. AD and DD were positively associated with lung, blood, and liver cancers, while AD was also associated with prostate cancer. A dose-response relationship was observed between depressive symptom severity and cancer risk. Conclusion MHCs were associated with a higher risk of overall and some site-specific cancers. While causality cannot be assumed, diagnoses of MHCs could be useful for cancer risk stratification and prevention.

2 July 2026 in PLOS Medicine
Verified
Journal Article
Open access
ZZZiyi Zhou
Ziyi Zhou
STStewart G. Trost
Stewart G. Trost
GRGemma C. Ryde
Gemma C. Ryde
SPSolange Parra-Soto
Solange Parra-Soto
ZFZhe Fang
Zhe Fang
FHFrederick Ho
Frederick Ho
Background: Current sedentary behavior (SB) guidelines primarily emphasize total time spent sedentary. We explored differences between interrupted and prolonged SB in relation to a range of cancer outcomes. Methods and findings: This study included 91,292 UK Biobank participants with valid accelerometer data. Participants were followed for a median of 12.38 years (interquartile range 11.56–13.15 years). A two-step approach based on a random forest model was used to classify SB. Multivariable Cox proportional hazards models were applied to overall incident cancers and cancer deaths, plus obesity-related and type-2 diabetes-related cancers, and 23 site-specific cancers. Models were adjusted for demographic, socioeconomic, lifestyle, dietary, and health-status factors, including age, ethnicity, deprivation, education, smoking, alcohol intake, diet, and morbidity count. Isotemporal substitution models were used to estimate the associated cancer risk when replacing prolonged SB with intermittent SB, or physical activity (PA). After adjusting for sociodemographic and lifestyle factors, each additional hour of prolonged SB was associated with a higher risk of overall cancer mortality (hazard ratio [HR] HR 1hour 1.09; 95% confidence interval [CI] [1.06, 1.11]; p < 0.001). Replacing 1 hour per day of prolonged SB with light PA (HR LPA 0.88; 95% CI [0.79, 0.99]; p = 0.033) was associated with lower risk of overall cancer mortality. Similarly, replacing 30 min per day of prolonged SB with moderate PA (HR MPA 0.92; 95% CI [0.86, 0.99]; p = 0.024) was associated with a lower risk of overall cancer mortality. The main methodological limitations were observational design, residual confounding, healthy volunteer bias, and measurement imprecision due to having only 7 days of accelerometer wear. Conclusion: Cancer risk associated with SB is specific to prolonged SB. Replacing prolonged SB physical activity is associated with lower cancer risk.